Lineage Cell Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Lineage Cell Therapeutics's balance sheet done over the years? Its assets were worth $101,019,000 last year, which is less than in the previous period. 39% of Lineage Cell Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $38,996,000, which means an decrease by -25% compared compared to last year.
Debt to Assets
| 2014 | 74900906 | 12.17M | 16.26% |
|---|---|---|---|
| 2015 | 94660000 | 18.21M | 19.24% |
| 2016 | 142572000 | 12.06M | 8.46% |
| 2017 | 173241000 | 8.97M | 5.18% |
| 2018 | 101660000 | 9.41M | 9.26% |
| 2019 | 125478000 | 14.23M | 11.34% |
| 2020 | 107949000 | 12.82M | 11.88% |
| 2021 | 174545000 | 83.64M | 47.92% |
| 2022 | 123664000 | 51.72M | 41.83% |
| 2023 | 101019000 | 38.99M | 38.6% |
LCTX Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 35.44M | 11.35M | 55.74M | 32.58M | 9.49M | 23.58M | 36.83M | 22.08M | 42.22M | 29.48M |
Short term investments | 50K | 46.52M | 2.61M | 8.97M | 21.21M | 7.15M | 1.33M | 627K | 753K | 3K |
Net receivables | 745K | 297K | 50.84M | 4K | 23.94M | 3.71M | 3.04M | 1.15M | 1.64M | 1.04M |
Inventory | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1K | 266.02K |
Other current assets | 2.20M | 1.82M | 2.35M | 2.43M | 2.86M | 1.89M | 1.40M | 1.77M | 3.17M | 1.60M |
Total current assets | 38.44M | 60M | 111.54M | 43.99M | 57.51M | 36.35M | 42.62M | 25.64M | 47.23M | 32.40M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 4.76M | 5.67M | 4.87M | 5.63M | 8.17M | 5.83M | 5.53M | 5.52M | 7.53M | 2.85M |
Goodwill | 10.67M | 10.67M | 10.67M | 10.67M | 10.67M | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 46.56M | 46.69M | 46.82M | 47.03M | 48.24M | 3.12M | 6.9M | 10.20M | 33.59M | 38.84M |
Long term investments | 0 | 581K | 535K | 520K | 100K | 33.73M | 117.16M | 100.03M | 4.67M | 0 |
Other non-current assets | 577K | 627K | 630K | 616K | 864K | 505K | 1.01M | 1.03M | 1.29M | 790.10K |
Total non-current assets | 62.57M | 63.66M | 62.99M | 63.95M | 67.95M | 65.30M | 130.61M | 116.92M | 47.42M | 42.49M |
Total assets | 101.01M | 123.66M | 174.54M | 107.94M | 125.47M | 101.66M | 173.24M | 142.57M | 94.66M | 74.90M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 10.80M | 9.42M | 18.11M | 193K | 45K | 42K | 797K | 572K | 2.95M | 208.35K |
Short term debt | 1.76M | 952K | 831K | 762K | 1.22M | 307K | 364K | 1.13M | 133K | 175.73K |
Total current liabilities | 17.96M | 18.98M | 47.11M | 7.76M | 6.49M | 6.81M | 6.87M | 8.85M | 12.46M | 7.12M |
| Non-current liabilities: | ||||||||||
Long term debt | 2.07M | 2.94M | 1.97M | 2.54M | 3.94M | 1.95M | 1.16M | 2.84M | 4.97M | 469K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 2K | 30K | 437K | 277K | 644K | 930K | 8K | 166K | 65.51K |
Total non-current liabilities | 21.03M | 32.74M | 36.53M | 5.05M | 7.73M | 2.60M | 2.09M | 3.21M | 5.75M | 5.04M |
Total liabilities | 38.99M | 51.72M | 83.64M | 12.82M | 14.23M | 9.41M | 8.97M | 12.06M | 18.21M | 12.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |